[{"id":"9b130205-eeec-4a02-996a-184a84884dda","acronym":"","url":"https://clinicaltrials.gov/study/NCT05088070","created_at":"2021-10-21T12:53:13.242Z","updated_at":"2024-07-02T16:35:03.984Z","phase":"Phase 1","brief_title":"Clinical Study of SPH3348 Tablets, a c-Met Inhibitor, in Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT05088070","lead_sponsor":"Shanghai Pharmaceuticals Holding Co., Ltd","biomarkers":" MET","pipe":"","alterations":" ","tags":["MET"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SPH 3348"],"overall_status":"Recruiting","enrollment":" Enrollment 231","initiation":"Initiation: 07/02/2020","start_date":" 07/02/2020","primary_txt":" Primary completion: 07/30/2024","primary_completion_date":" 07/30/2024","study_txt":" Completion: 12/30/2024","study_completion_date":" 12/30/2024","last_update_posted":"2024-05-14"}]